북미의 수의용 비타민 제조 시장 규모, 점유율, 동향 분석 보고서 : 동물별, 제품별, 유형별, 제형별, 밸류체인별, 국가별 및 부문별 예측(2026-2033년)

North America Veterinary Vitamin Manufacturing Market Summary

The North America veterinary vitamin manufacturing market size was valued at USD 439.5 million in 2025 and is projected to grow from USD 456.9 million in 2026 to USD 764.3 million by 2033, at a CAGR of 7.6% from 2026 to 2033. The market growth is driven by large livestock and poultry production, rising companion animal ownership, increasing adoption of preventive animal healthcare, and growing demand for feed-grade vitamin premixes.

Other factors contributing to market growth include advanced feed manufacturing infrastructure, stringent animal welfare and food safety standards, antimicrobial stewardship initiatives, higher pet wellness spending, and the presence of established animal health, nutrition, and contract manufacturing companies.

North America Veterinary Vitamin Manufacturing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America Veterinary Vitamin Manufacturing market report based on animal, product, type, dosage form, value chain, and country.

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Companion Animals
• Production Animals
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Vitamin B-Complex
• Vitamin B12
• Vitamin K
• Vitamin D3
• Other Vitamins
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• API
• Finished Drug Products
• Dosage Form Outlook (Revenue, USD Million, 2021 - 2033)
• Oral
• Injectables
• Value Chain Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biopharmaceutical Companies
• Animal Feed & Nutrition Companies
• CMO/CDMOs
• Others
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• U.S.
• Canada
• Mexico

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Animal
  • 1.2.2. Product
  • 1.2.3. Type
  • 1.2.4. Dosage Form
  • 1.2.5. Value Chain
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom-Up Analysis
  • 1.7.3. Model 3 Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Preventive Animal Health Care
    • 3.2.1.2. Growing Livestock & Poultry Productivity Needs
    • 3.2.1.3. Increasing Pet Health Humanization
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Rising Vitamin Raw Material Price Volatility
    • 3.2.2.2. Stability Challenges in Veterinary Vitamin Formulations
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Price & Cost Structure Analysis
• 3.4. Tariff & Trade Impact Analysis
• 3.5. Value Chain Analysis
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. North America Veterinary Vitamin Manufacturing Market: Animal Estimates & Trend Analysis

• 4.1. North America Veterinary Vitamin Manufacturing Market by Animal, Segment Dashboard
• 4.2. North America Veterinary Vitamin Manufacturing Market: Animal Movement Analysis
• 4.3. North America Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
• 4.4. Production Animals
  • 4.4.1. Production Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Companion Animals
  • 4.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America Veterinary Vitamin Manufacturing Market: Product Estimates & Trend Analysis

• 5.1. North America Veterinary Vitamin Manufacturing Market by Product, Segment Dashboard
• 5.2. North America Veterinary Vitamin Manufacturing Market: Product Movement Analysis
• 5.3. North America Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 5.4. Vitamin B-complex
  • 5.4.1. Vitamin B-complex Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Vitamin B12
  • 5.5.1. Vitamin B12 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Vitamin K
  • 5.6.1. Vitamin K Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Vitamin D3
  • 5.7.1. Vitamin D3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Other Vitamins
  • 5.8.1. Other Vitamins Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America Veterinary Vitamin Manufacturing Market: Type Estimates & Trend Analysis

• 6.1. North America Veterinary Vitamin Manufacturing Market by Type, Segment Dashboard
• 6.2. North America Veterinary Vitamin Manufacturing Market: Type Movement Analysis
• 6.3. North America Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 6.4. API
  • 6.4.1. API Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Finished Drug Products
  • 6.5.1. Finished Drug Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America Veterinary Vitamin Manufacturing Market: Dosage Form Estimates & Trend Analysis

• 7.1. North America Veterinary Vitamin Manufacturing Market by Dosage Form, Segment Dashboard
• 7.2. North America Veterinary Vitamin Manufacturing Market: Dosage Form Movement Analysis
• 7.3. North America Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Dosage Form, 2021 to 2033 (USD Million)
• 7.4. Oral
  • 7.4.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Injectables
  • 7.5.1. Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America Veterinary Vitamin Manufacturing Market: Value Chain Estimates & Trend Analysis

• 8.1. North America Veterinary Vitamin Manufacturing Market by Value Chain, Segment Dashboard
• 8.2. North America Veterinary Vitamin Manufacturing Market: Value Chain Movement Analysis
• 8.3. North America Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Value Chain, 2021 to 2033 (USD Million)
• 8.4. Pharmaceutical & Biopharmaceutical Companies
  • 8.4.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Animal Feed & Nutrition Companies
  • 8.5.1. Animal Feed & Nutrition Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. CMO/CDMOs
  • 8.6.1. CMO/CDMOs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Others
  • 8.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. North America Veterinary Vitamin Manufacturing Market: Country Estimates & Trend Analysis

• 9.1. Country Dashboard
• 9.2. North America Veterinary Vitamin Manufacturing Market Share, By Country, 2025 & 2033 (USD Million)
• 9.3. U.S.
  • 9.3.1. Key Country Dynamics
  • 9.3.2. Competitive Scenario
  • 9.3.3. Regulatory Framework
  • 9.3.4. U.S. North America Veterinary Vitamin Manufacturing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 9.4. Canada
  • 9.4.1. Key Country Dynamics
  • 9.4.2. Competitive Scenario
  • 9.4.3. Regulatory Framework
  • 9.4.4. Canada North America Veterinary Vitamin Manufacturing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 9.5. Mexico
  • 9.5.1. Key Country Dynamics
  • 9.5.2. Competitive Scenario
  • 9.5.3. Regulatory Framework
  • 9.5.4. Mexico North America Veterinary Vitamin Manufacturing Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
  • 10.1.1. Market Leaders
  • 10.1.2. Emerging Players
• 10.2. Company Market Position Analysis/ Heap Map Analysis, 2025
• 10.3. Company Profiles
  • 10.3.1. Merck & Co., Inc.
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Zoetis Services LLC
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Virbac
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Boehringer Ingelheim International GmbH
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Elanco
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. Phibro Animal Health Corporation
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. ADM Animal Nutrition.
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Vetoquinol
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Trouw Nutrition
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Dechra
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives